- Home
- KNSA vs CPRI Comparison
KNSA vs CPRI Comparison
Compare KNSA & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- CPRI
- Stock Information
- Founded
- KNSA 2015
- CPRI 1981
- Country
- KNSA United Kingdom
- CPRI United Kingdom
- Employees
- KNSA N/A
- CPRI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- CPRI Apparel
- Sector
- KNSA Health Care
- CPRI Consumer Discretionary
- Exchange
- KNSA Nasdaq
- CPRI Nasdaq
- Market Cap
- KNSA 1.9B
- CPRI 2.0B
- IPO Year
- KNSA 2018
- CPRI 2011
- Fundamental
- Price
- KNSA $28.44
- CPRI $16.82
- Analyst Decision
- KNSA Strong Buy
- CPRI Buy
- Analyst Count
- KNSA 5
- CPRI 11
- Target Price
- KNSA $38.80
- CPRI $21.91
- AVG Volume (30 Days)
- KNSA 707.0K
- CPRI 3.1M
- Earning Date
- KNSA 07-22-2025
- CPRI 08-07-2025
- Dividend Yield
- KNSA N/A
- CPRI N/A
- EPS Growth
- KNSA N/A
- CPRI N/A
- EPS
- KNSA N/A
- CPRI N/A
- Revenue
- KNSA $481,166,000.00
- CPRI $4,442,000,000.00
- Revenue This Year
- KNSA $37.21
- CPRI N/A
- Revenue Next Year
- KNSA $5.32
- CPRI $4.55
- P/E Ratio
- KNSA N/A
- CPRI N/A
- Revenue Growth
- KNSA 59.45
- CPRI N/A
- 52 Week Low
- KNSA $17.38
- CPRI $11.86
- 52 Week High
- KNSA $30.69
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- KNSA 55.24
- CPRI 46.41
- Support Level
- KNSA $27.62
- CPRI $16.75
- Resistance Level
- KNSA $28.69
- CPRI $17.50
- Average True Range (ATR)
- KNSA 1.13
- CPRI 0.67
- MACD
- KNSA -0.28
- CPRI -0.12
- Stochastic Oscillator
- KNSA 45.78
- CPRI 14.44
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. In April 2025, Capri agreed to sell Versace to Prada. John Idol has served as Capri's CEO since 2003.